首页> 美国卫生研究院文献>Nature Public Health Emergency Collection >Low frequency of CD3+CD4+CD161+ T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment

【2h】

Low frequency of CD3+CD4+CD161+ T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment

机译：CD3 + CD4 + CD161 + T细胞的低频率与接受来那度胺联合小剂量地塞米松治疗的难治性/复发性多发性骨髓瘤患者的感染发生有关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

The online version of this article (10.1007/s00277-018-3401-y) contains supplementary material, which is available to authorized users.

机译：本文的在线版本（10.1007 / s00277-018-3401-y）包含补充材料，可供授权用户使用。

著录项

期刊名称 Nature Public Health Emergency Collection
作者
Sung-Eun Lee; Ji-Young Lim; Da-Bin Ryu; Tae Woo Kim; Sung Soo Park; Young-Woo Jeon; Jae-Ho Yoon; Byung-Sik Cho; Ki-Seong Eom; Yoo-Jin Kim; Hee-Je Kim; Seok Lee; Seok-Goo Cho; Dong-Wook Kim; Jong Wook Lee; Chang-Ki Min;
展开▼
作者单位

展开▼
年(卷),期 -1(97),11
年度 -1
页码 -1
总页数 9
原文格式 PDF
正文语种
中图分类精神病学;
关键词
Multiple myeloma; Lenalidomide; Low-dose dexamethasone; Infection; CD4;

机译：多发性骨髓瘤;来那度胺;小剂量地塞米松;感染;CD4;

相似文献

外文文献
中文文献
专利

1. Low frequency of CD3(+)CD4(+)CD161(+) T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment [J] . Lee Sung-Eun, Lim Ji-Young, Ryu Da-Bin, Annals of hematology . 2018,第11期

机译：CD3（+）CD161（+）CD161（+）T细胞的低频与接受Lenalidomide加低剂量地塞米松治疗的难治性/复发患者的难治性/复发患者的感染发生相关
2. Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma [J] . Lee Sung-Eun, Lim Ji-Young, Ryu Da-Bin, Cancer immunology, immunotherapy : . 2016,第8期

机译：循环免疫细胞表型可以预测来那度胺联合小剂量地塞米松治疗难治性/复发性多发性骨髓瘤的疗效
3. Low-dose lenalidomide and dexamethasone combination treatment in elderly patients with relapsed and refractory multiple myeloma [J] . Chunling Wang, Zhengmei He, Yuye Shi, Hematology . 2017,第2期

机译：小剂量来那度胺和地塞米松联合治疗老年复发难治性多发性骨髓瘤
4. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
5. Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma [O] . Seung-Hyun Jung, Sung-Eun Lee, Minho Lee, 2017

机译：循环中的microRNA表达可预测来那度胺联合小剂量地塞米松治疗难治性/复发性多发性骨髓瘤患者的疗效
6. Low-dose lenalidomide and dexamethasone combination treatment in elderly patients with relapsed and refractory multiple myeloma [O] . Chunling Wang, Zhengmei He, Yuye Shi, 2016

机译：低剂量的Lenalidomide和Dexamethasone在老年患者复发和难治性多发性骨髓瘤中的组合治疗

Low frequency of CD3+CD4+CD161+ T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅